Literature DB >> 8239501

The analysis of ifosfamide and its metabolites (review).

G P Kaijser1, A Korst, J H Beijnen, A Bult, W J Underberg.   

Abstract

Ifosfamide is a member of the oxazaphosphorine class of cytostatic drugs. Ifosfamide has to be metabolized prior to expressing its cytotoxicity. This metabolism leads to a great variety of metabolites. An overview is given of the methods of analysis of ifosfamide and its metabolites as well as the current knowledge about its metabolism, toxicity and clinical use in relation to the bio-analysis. For ifosfamide and some of its metabolites reliable methods of analysis exist. However, for the most important metabolites, isofosforamide mustard and acrolein, progress has to be made in improving the simplicity and sensitivity of the existing methods.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8239501

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  8 in total

Review 1.  Clinical pharmacokinetics and pharmacodynamics of ifosfamide and its metabolites.

Authors:  T Kerbusch; J de Kraker; H J Keizer; J W van Putten; H J Groen; R L Jansen; J H Schellens; J H Beijnen
Journal:  Clin Pharmacokinet       Date:  2001-01       Impact factor: 6.447

2.  Acrolein cytotoxicity in hepatocytes involves endoplasmic reticulum stress, mitochondrial dysfunction and oxidative stress.

Authors:  Mohammad K Mohammad; Diana Avila; Jingwen Zhang; Shirish Barve; Gavin Arteel; Craig McClain; Swati Joshi-Barve
Journal:  Toxicol Appl Pharmacol       Date:  2012-09-28       Impact factor: 4.219

Review 3.  Interactions between antiretrovirals and antineoplastic drug therapy.

Authors:  Tony Antoniou; Alice L Tseng
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

4.  Relationship of glutathione S-transferase genotypes with side-effects of pulsed cyclophosphamide therapy in patients with systemic lupus erythematosus.

Authors:  Shilong Zhong; Min Huang; Xiuyan Yang; Liuqin Liang; Yixi Wang; Marjorie Romkes; Wei Duan; Eli Chan; Shu-Feng Zhou
Journal:  Br J Clin Pharmacol       Date:  2006-10       Impact factor: 4.335

Review 5.  Mass Spectrometry-Based Tools to Characterize DNA-Protein Cross-Linking by Bis-Electrophiles.

Authors:  Arnold Groehler; Amanda Degner; Natalia Y Tretyakova
Journal:  Basic Clin Pharmacol Toxicol       Date:  2017-03-14       Impact factor: 4.080

6.  Kinetics and mechanism of protein tyrosine phosphatase 1B inactivation by acrolein.

Authors:  Derrick R Seiner; Jason N LaButti; Kent S Gates
Journal:  Chem Res Toxicol       Date:  2007-07-27       Impact factor: 3.739

Review 7.  Pharmacogenomics: a tool for improving cancer chemotherapy.

Authors:  Mariano Monzó; Alfons Navarro; Gerardo Ferrer; Rosa Artells
Journal:  Clin Transl Oncol       Date:  2008-10       Impact factor: 3.405

8.  The pharmacokinetics and metabolism of ifosfamide during bolus and infusional administration: a randomized cross-over study.

Authors:  J M Singer; J M Hartley; C Brennan; P W Nicholson; R L Souhami
Journal:  Br J Cancer       Date:  1998-03       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.